Yingnan Yu

494 total citations
11 papers, 152 citations indexed

About

Yingnan Yu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Yingnan Yu has authored 11 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in Yingnan Yu's work include Cancer Mechanisms and Therapy (3 papers), Chromatin Remodeling and Cancer (3 papers) and Peptidase Inhibition and Analysis (2 papers). Yingnan Yu is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Chromatin Remodeling and Cancer (3 papers) and Peptidase Inhibition and Analysis (2 papers). Yingnan Yu collaborates with scholars based in Singapore, China and Japan. Yingnan Yu's co-authors include Boon‐Huat Bay, Aye Aye Thike, Puay Hoon Tan, Ken Matsumoto, Steve Rozen, Yoko Itahana, P. Mathijs Voorhoeve, Qiang Yu, Patrick Tan and Na‐Yu Chia and has published in prestigious journals such as Clinical Cancer Research, Cell Death and Differentiation and Bone.

In The Last Decade

Yingnan Yu

10 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yingnan Yu Singapore	7	110	54	31	18	17	11	152
Ankita Sati Batra India	7	116 1.1×	73 1.4×	61 2.0×	24 1.3×	17 1.0×	10	196
Dhanya Kalathil India	4	89 0.8×	26 0.5×	24 0.8×	18 1.0×	14 0.8×	9	123
Deji Ye China	5	109 1.0×	26 0.5×	61 2.0×	11 0.6×	12 0.7×	7	151
Sina Hossaini United Kingdom	4	87 0.8×	99 1.8×	30 1.0×	10 0.6×	16 0.9×	8	175
Saira Khalique United Kingdom	7	107 1.0×	72 1.3×	19 0.6×	43 2.4×	23 1.4×	11	193
S. Lindsey Davis United States	5	41 0.4×	45 0.8×	15 0.5×	13 0.7×	15 0.9×	8	95
Wenle Tan China	7	81 0.7×	40 0.7×	40 1.3×	9 0.5×	28 1.6×	12	134
Jianong Zhang China	8	101 0.9×	37 0.7×	50 1.6×	7 0.4×	29 1.7×	10	140
Synnøve Yndestad Norway	6	78 0.7×	50 0.9×	50 1.6×	5 0.3×	20 1.2×	9	118
Bob Meeusen Belgium	6	105 1.0×	37 0.7×	26 0.8×	7 0.4×	10 0.6×	7	129

Countries citing papers authored by Yingnan Yu

Since Specialization

Citations

This map shows the geographic impact of Yingnan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingnan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingnan Yu more than expected).

Fields of papers citing papers by Yingnan Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingnan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingnan Yu. The network helps show where Yingnan Yu may publish in the future.

Co-authorship network of co-authors of Yingnan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingnan Yu. A scholar is included among the top collaborators of Yingnan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingnan Yu. Yingnan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

He, Yilin, Yongfeng Liu, YiJiang Song, et al.. (2025). ARID1A loss enhances sensitivity to c-MET inhibition by dual targeting of GPX4 and iron homeostasis, inducing ferroptosis. Cell Death and Differentiation. 32(11). 2009–2021. 3 indexed citations

Wang, Zhen, Yingnan Yu, Zelong Han, et al.. (2024). ARID1A loss sensitizes colorectal cancer cells to floxuridine. Neoplasia. 58. 101069–101069.

Song, YiJiang, Yilin He, Yingnan Yu, et al.. (2024). Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis). Cell Death and Disease. 15(5). 375–375. 8 indexed citations

Wu, Yimin, et al.. (2023). Association of LINC-PINT polymorphisms with lumbar disc herniation risk among Chinese Han population: a case control study. Journal of Orthopaedic Surgery and Research. 18(1). 585–585. 1 indexed citations

Chen, Sylvia, et al.. (2016). Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review. Drug Metabolism Reviews. 48(4). 502–540. 19 indexed citations

Scully, Olivia Jane, Yingnan Yu, Agus Salim, et al.. (2015). Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer. Experimental Biology and Medicine. 240(7). 846–853. 13 indexed citations

Zhou, Fiona H., Yingnan Yu, Xin‐Fu Zhou, & Cory J. Xian. (2014). Methotrexate chemotherapy triggers touch-evoked pain and increased CGRP-positive sensory fibres in the tibial periosteum of young rats. Bone. 73. 24–31. 3 indexed citations

Guo, Tiantian, Yingnan Yu, Gyeong Hun Baeg, et al.. (2014). Y‐box binding protein 1 is correlated with lymph node metastasis in intestinal‐type gastric cancer. Histopathology. 66(4). 491–499. 20 indexed citations

Itahana, Yoko, Na‐Yu Chia, Yonghui Wu, et al.. (2012). TP53 Genomic Status Regulates Sensitivity of Gastric Cancer Cells to the Histone Methylation Inhibitor 3-Deazaneplanocin A (DZNep). Clinical Cancer Research. 18(15). 4201–4212. 67 indexed citations

10.

Inoue, Ikuyo, Ken Matsumoto, Yingnan Yu, & Boon‐Huat Bay. (2011). Surmounting Chemoresistance by Targeting the Y‐Box Binding Protein‐1. The Anatomical Record. 295(2). 215–222. 10 indexed citations

11.

Yu, Yingnan, Hui Chen, & Yan Li. (2008). Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice. Archives of Toxicology. 83(4). 381–387. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact